| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.04▼ | 6.01▼ | 6.00▼ | 5.99▼ | 5.18▲ |
| MA10 | 6.05▼ | 6.01▼ | 6.02▼ | 5.60▲ | 4.62▲ |
| MA20 | 6.02▼ | 6.00▼ | 5.96▲ | 4.83▲ | 3.77▲ |
| MA50 | 6.01▼ | 5.93▲ | 5.92▲ | 4.43▲ | 2.25▲ |
| MA100 | 6.02▼ | 5.85▲ | 5.08▲ | 3.45▲ | 2.70▲ |
| MA200 | 5.95▲ | 5.02▲ | 4.53▲ | 2.38▲ | 3.36▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.006▼ | -0.011▼ | 0.147▲ | 0.192▲ |
| RSI | 42.003▼ | 49.651▼ | 52.259▲ | 74.148▲ | 80.012▲ |
| STOCH | 44.444 | 31.051 | 43.708 | 88.931▲ | 71.188 |
| WILL %R | -100.000▼ | -68.675 | -56.436 | -11.609▲ | -8.273▲ |
| CCI | -187.361▼ | -31.184 | 25.327 | 74.505 | 174.227▲ |
|
Friday, March 06, 2026 02:46 PM
Shattuck Labs (NASDAQ: STTK) was an outlier in the healthcare sector this week, thanks mostly to a very well-received earnings report and business update. Over the five trading days, according to data ...
|
|
Thursday, March 05, 2026 04:45 AM
Phase 1 clinical trial of SL-325 ongoing, with data expected in the second quarter of 2026 –Phase 2 clinical trial of SL-325 in patients with Crohn’s disease expected to initiate in the third quarter ...
|
|
Wednesday, February 25, 2026 12:00 AM
AUSTIN, TX and DURHAM, NC, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/03/26 | 6.01 | 6.265 | 5.935 | 5.98 | 494,604 |
| 13/03/26 | 6.21 | 6.25 | 5.75 | 5.99 | 354,266 |
| 12/03/26 | 5.96 | 6.13 | 5.56 | 6.13 | 452,247 |
| 11/03/26 | 5.90 | 6.16 | 5.85 | 5.88 | 361,018 |
| 10/03/26 | 5.98 | 6.25 | 5.84 | 5.96 | 424,401 |
| 09/03/26 | 6.04 | 6.25 | 5.75 | 6.02 | 836,839 |
| 06/03/26 | 5.27 | 6.00 | 5.2019 | 5.99 | 2,516,048 |
| 05/03/26 | 4.56 | 5.19 | 4.56 | 5.10 | 1,503,043 |
| 04/03/26 | 4.28 | 4.73 | 4.23 | 4.73 | 2,004,808 |
| 03/03/26 | 3.89 | 4.27 | 3.89 | 4.23 | 705,640 |
|
|
||||
|
|
||||
|
|